Reviva Pharmaceuticals (RVPH) PT Lowered to $6 at Maxim Group
Tweet
Share
E-mailGet Alerts RVPH Hot Sheet
Price: $0.35 --0%
Rating Summary:
5 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
5 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
Maxim Group analyst Jason McCarthy lowered the price target on Reviva Pharmaceuticals (NASDAQ: RVPH) to $6.00 (from $18.00) while maintaining a Buy rating.
You May Also Be Interested In
- Oracle (ORCL) PT Raised to $250 at UBS Following Q1 Results
- HubSpot Inc (HUBS) PT Raised to $225 at Stifel Ahead of UNBOUND Conference
- Jazz Pharmaceuticals (JAZZ) PT Raised to $337 at UBS on GEA Approval for Ziihera
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
